Family Medicine · Flemingsburg, KY
NPI
1740270115
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
935 Elizaville Ave
Flemingsburg, KY, 41041
Phone (606) 849-3374
Groups this clinician bills Medicare through
Medicare paid, 2024
$129K
4,599 services
Medicare patients, 2024
395
Average age 75
Drug cost, 2024
$2.0M
28,924 prescriptions
Company payments, 2025
$1,431
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael A Boyd was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,124 times for 19 patients. In total Michael A Boyd billed 4,599 services in 59 codes, and Medicare paid $129K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,124 | 19 | $0.09 | $96.87 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 828 | 84 | $0.07 | $59.7 |
| 99213 Office E&M - Established | Office | 755 | 243 | $54.57 | $41K |
| 99214 Office E&M - Established | Office | 274 | 150 | $77.27 | $21K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 268 | 31 | $0.61 | $163 |
| 99309 SNF E&M | Office | 241 | 62 | $79.40 | $19K |
| 83036 Blood Count | Office | 163 | 60 | $9.35 | $1,524 |
| 99309 SNF E&M | Facility | 159 | 30 | $75.09 | $12K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 136 | 35 | $0.31 | $42.62 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 63 | 63 | $123.23 | $7,763 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 51 | 15 | $0.83 | $42.17 |
| 81003 Clinical Chemistry | Office | 50 | 33 | $2.20 | $110 |
| 90662 Vaccine Product | Office | 37 | 36 | $81.29 | $3,008 |
| G0008 Administration of influenza virus vaccine | Office | 37 | 36 | $29.43 | $1,089 |
| 99306 SNF E&M | Office | 25 | 25 | $123.62 | $3,090 |
By year: 2022 $142K for 4,204 services; 2023 $142K for 4,165 services; 2024 $129K for 4,599 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 163 | 60 | $9.35 | $1,524 |
| 81003 Clinical Chemistry | 50 | 33 | $2.20 | $110 |
| 87804 Immunoassay | 22 | 12 | $15.59 | $343 |
| 87426 Immunoassay | 19 | 18 | $32.91 | $625 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael A Boyd prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,065 prescriptions and refills. In total Michael A Boyd wrote 28,924 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,065 | 1,853 | 215 | $8,961 |
| Levothyroxine Sodium Generic | 1,041 | 1,826 | 183 | $9,503 |
| Lisinopril Generic | 772 | 1,510 | 162 | $3,784 |
| Omeprazole Generic | 746 | 1,314 | 145 | $5,774 |
| Pantoprazole Sodium Generic | 741 | 1,142 | 140 | $13K |
| Amlodipine Besylate Generic | 651 | 1,013 | 112 | $2,918 |
| Furosemide Generic | 647 | 816 | 126 | $3,254 |
| Gabapentin Generic | 621 | 797 | 102 | $6,727 |
| Prednisone Generic | 609 | 609 | 283 | $1,512 |
| Alprazolam Generic | 564 | 579 | 91 | $2,508 |
| Losartan Potassium Generic | 456 | 865 | 93 | $3,802 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 453 | 461 | 81 | $7,586 |
| Metoprolol Tartrate Generic | 444 | 630 | 67 | $3,183 |
| Citalopram Hbr Citalopram Hydrobromide | 426 | 670 | 75 | $2,038 |
| Potassium Chloride Generic | 387 | 465 | 62 | $9,797 |
Brand drugs: 3,281 claims; generic drugs: 25,445 claims; opioid claims: 1,078.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael A Boyd $1,431 ($1,431 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $313.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $313 |
| Abbvie Inc. ABBV | 10 | $199 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $196 |
| Novo Nordisk Inc NVO | 5 | $119 |
| Phathom Pharmaceuticals, Inc. PHAT | 6 | $107 |
| Sumitomo Pharma America, Inc. 4506.T | 6 | $97.86 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $65.77 |
| Lilly USA, LLC LLY | 3 | $49.24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $47.96 |
| Pfizer Inc. PFE | 3 | $47.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.